IL52615A - 1-aza-prostaglandin analogues,their preparation and pharmaceutical compositions containing them - Google Patents

1-aza-prostaglandin analogues,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL52615A
IL52615A IL52615A IL5261577A IL52615A IL 52615 A IL52615 A IL 52615A IL 52615 A IL52615 A IL 52615A IL 5261577 A IL5261577 A IL 5261577A IL 52615 A IL52615 A IL 52615A
Authority
IL
Israel
Prior art keywords
aza
preparation
pharmaceutical compositions
compositions containing
prostaglandin analogues
Prior art date
Application number
IL52615A
Other languages
English (en)
Other versions
IL52615A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL52615A0 publication Critical patent/IL52615A0/xx
Publication of IL52615A publication Critical patent/IL52615A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL52615A 1976-08-06 1977-07-28 1-aza-prostaglandin analogues,their preparation and pharmaceutical compositions containing them IL52615A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (2)

Publication Number Publication Date
IL52615A0 IL52615A0 (en) 1977-10-31
IL52615A true IL52615A (en) 1981-09-13

Family

ID=24861795

Family Applications (1)

Application Number Title Priority Date Filing Date
IL52615A IL52615A (en) 1976-08-06 1977-07-28 1-aza-prostaglandin analogues,their preparation and pharmaceutical compositions containing them

Country Status (31)

Country Link
JP (2) JPS5321159A (bg)
AR (1) AR217080A1 (bg)
AT (1) AT362887B (bg)
AU (1) AU508007B2 (bg)
BE (1) BE857506A (bg)
BG (1) BG31073A3 (bg)
CA (1) CA1077948A (bg)
CH (1) CH624934A5 (bg)
CS (1) CS221269B2 (bg)
DD (2) DD143768A5 (bg)
DE (1) DE2735904A1 (bg)
DK (1) DK352077A (bg)
ES (2) ES461388A1 (bg)
FI (1) FI70009C (bg)
FR (1) FR2369260A1 (bg)
GB (2) GB1556569A (bg)
GR (1) GR68688B (bg)
HU (1) HU180273B (bg)
IE (1) IE45505B1 (bg)
IL (1) IL52615A (bg)
LU (1) LU77936A1 (bg)
NL (1) NL7708637A (bg)
NO (1) NO772752L (bg)
NZ (1) NZ184806A (bg)
PH (1) PH17398A (bg)
PL (2) PL112931B1 (bg)
PT (1) PT66891B (bg)
SE (1) SE423813B (bg)
SU (3) SU703016A3 (bg)
YU (1) YU192577A (bg)
ZA (1) ZA774704B (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
JPS59137224A (ja) * 1983-01-25 1984-08-07 Mitsubishi Electric Corp 電気鉄道用き電電圧補償装置
ATE327751T1 (de) 2000-01-31 2006-06-15 Pfizer Prod Inc Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
PT1339678E (pt) * 2000-11-27 2007-11-30 Pfizer Prod Inc Agonistas selectivos do receptor ep4 no tratamento de osteoporose
TWI313608B (en) * 2001-07-23 2009-08-21 Ono Pharmaceutical Co Lower bone mass treating agent containing er4 agonist as active ingredient
MXPA04005555A (es) * 2002-03-18 2005-05-16 Pfizer Prod Inc Procedimientos de tratamiento con agonistas selectivos del receptor ep4.
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
US7256211B1 (en) * 2003-01-21 2007-08-14 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medical use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (ja) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22piroridonjudotaino seiho
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (de) * 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CA1077948A (en) 1980-05-20
SE7708642L (sv) 1978-02-07
GB1556570A (en) 1979-11-28
DD143768A5 (de) 1980-09-10
PL200124A1 (pl) 1978-05-22
AR217080A1 (es) 1980-02-29
JPS5555161A (en) 1980-04-22
GR68688B (bg) 1982-02-01
IL52615A0 (en) 1977-10-31
ZA774704B (en) 1978-06-28
JPS5531147B2 (bg) 1980-08-15
SE423813B (sv) 1982-06-07
YU192577A (en) 1983-04-30
IE45505L (en) 1978-02-06
CS221269B2 (en) 1983-04-29
BE857506A (fr) 1978-02-06
NL7708637A (nl) 1978-02-08
FR2369260B1 (bg) 1982-02-12
AU2751577A (en) 1979-02-08
NZ184806A (en) 1980-04-28
AT362887B (de) 1981-06-25
PH17398A (en) 1984-08-08
NO772752L (no) 1978-02-07
JPS585196B2 (ja) 1983-01-29
ATA579477A (de) 1980-11-15
FI70009B (fi) 1986-01-31
FI70009C (fi) 1986-09-12
PT66891B (en) 1979-01-26
SU850000A3 (ru) 1981-07-23
FI772376A (bg) 1978-02-07
DE2735904A1 (de) 1978-02-09
LU77936A1 (bg) 1978-04-27
ES461388A1 (es) 1978-12-01
BG31073A3 (bg) 1981-10-15
DD136135A5 (de) 1979-06-20
IE45505B1 (en) 1982-09-08
JPS5321159A (en) 1978-02-27
DK352077A (da) 1978-02-07
AU508007B2 (en) 1980-03-06
HU180273B (en) 1983-02-28
PL112931B1 (en) 1980-11-29
GB1556569A (en) 1979-11-28
ES471349A1 (es) 1979-09-16
CH624934A5 (bg) 1981-08-31
FR2369260A1 (fr) 1978-05-26
SU703016A3 (ru) 1979-12-05
SU818480A3 (ru) 1981-03-30
PT66891A (en) 1977-09-01

Similar Documents

Publication Publication Date Title
IL51660A0 (en) Hentriakontapeptides their preparation and pharmaceutical compositions containing them
IL53063A (en) Phenoxy-amino-propanols,processes for their preparation and pharmaceutical compositions comprising them
IL52131A (en) Substituted 4-amino-4-arylcyclohexanones and their ketals,their preparation and pharmaceutical compositions containing them
IL51816A (en) Steroids,their preparation and pharmaceutical compositions containing them
IL53043A (en) N-heterocyclylalkyl-(1-aryloxy-2-hydroxy-3-amino-propane)derivatives,their preparation and pharmaceutical compositions containing them
IL54238A (en) Beta-endorphin analogues,their preparation and pharmaceutical compositions containing them
IL49325A (en) 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them
IL51309A0 (en) New 1,2-benzisothiazolin-3-ones,their preparation and pharmaceutical compositions containing them
IL52615A (en) 1-aza-prostaglandin analogues,their preparation and pharmaceutical compositions containing them
IL52717A (en) Derivatives of2-phenylamino-imidazoline-(2),their preparation and pharmaceutical compositions containing them
IL51428A (en) 3-substituted-4-aminoalkoxy-5,6-condensed ring-(2h)-pyran-2-ones,their preparation and pharmaceutical compositions containing them
IL52857A (en) Oxo-benzopyrane derivatives,their preparation and pharmaceutical compositions containing them
IL52137A (en) N-heterocyclic-n-(hetero)arylfluoroalkylamines,their preparation and pharmaceutical compositions containing them
MY8000099A (en) Isobutyramides, their preparation and therapeutic compositions containing them
IL50644A (en) 12-aza-11-oxo-15-hydroxyprostanoic acid analogues,their preparation and pharmaceutical compositions containing them
IL57504A0 (en) Prostagandin analogues,their preparation and pharmaceutical compositions containing
IL51468A (en) 17 -hydroxy- -d-homosteroid derivatives,their preparation and pharmaceutical compositions containing them
IL53552A (en) 1-piperazinopropanol esters,their preparation and pharmaceutical compositions containing them
IL53026A0 (en) New pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them
IL54899A (en) Pyridazinylhydrazones,their preparation and pharmaceutical compositions containing them
IL49099A (en) Xanthene-9-carboxylates, their preparation and pharmaceutical compositions containing them
IL50643A (en) 12-aza-11/oxo-9,9-dimethyl-15-hydroxy-prostanoic acid analogues their preparation and pharmaceutical compositions containing them
IL52952A (en) Hydroxymethyl-pyridine esters,their preparation and pharmaceutical compositions containing them
IL51373A (en) Pharmaceutical compositions containing halocinnamides,certain such compounds and their preparation
IL52853A0 (en) New aryl-alkylamines their preparation and pharmaceutical compositions containing them